MACROGENICS
MacroGenics, Inc., a biotechnology company, focuses on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases. The company is developing immune-based products, including monoclonal antibodies; and vaccines to prevent infections in healthy individuals. The company's Fc engineering technology enables to improve antibody functions to eliminate cancer cells. It is also developing products around the Dual Activating ReTargeting technology. The company was founded in 2000 and is headquartered in Rockville, Maryland.
MACROGENICS
Industry:
Biotechnology Health Care Manufacturing
Founded:
2000-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.macrogenics.com
Total Employee:
501+
Status:
Active
Contact:
3012515321
Email Addresses:
[email protected]
Total Funding:
165.92 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2008-07-17 | Raven Biotechnologies | Raven Biotechnologies acquired by MacroGenics | N/A |
2002-06-07 | Eliance Biotechnology | Eliance Biotechnology acquired by MacroGenics | N/A |
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - MacroGenics
Nextech Venture
Nextech Venture investment in Series D - MacroGenics
Eli Lilly & Company Foundation
Eli Lilly & Company Foundation investment in Series D - MacroGenics
Mitsubishi UFJ
Mitsubishi UFJ investment in Series D - MacroGenics
Arcus Ventures
Arcus Ventures investment in Series D - MacroGenics
TPG
TPG investment in Series D - MacroGenics
Innovis Investments
Innovis Investments investment in Series D - MacroGenics
Alta Partners
Alta Partners investment in Series D - MacroGenics
Ventures West
Ventures West investment in Series D - MacroGenics
CIDC Consultants
CIDC Consultants investment in Series D - MacroGenics
Key Employee Changes
Date | New article |
---|---|
2022-02-28 | MacroGenics Announces Executive Promotion |
Official Site Inspections
http://www.macrogenics.com Semrush global rank: 3.54 M Semrush visits lastest month: 4.15 K
- Host name: 77.113.185.35.bc.googleusercontent.com
- IP address: 35.185.113.77
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York